Beatty J A, Willett B J, Gault E A, Jarrett O
Department of Veterinary Pathology, University of Glasgow, Bearsden, United Kingdom.
J Virol. 1996 Sep;70(9):6199-206. doi: 10.1128/JVI.70.9.6199-6206.1996.
The evolution of the virus-specific cytotoxic T-lymphocyte response in two cats experimentally infected with feline immunodeficiency virus (FIV) was monitored. Effector cells were derived from peripheral blood lymphocytes during the acute and chronic phases of infection (0 to 21 and 62 to 127 weeks, respectively) and from the spleen and lymph nodes at 127 weeks after infection. Lymphocytes were restimulated in vitro with paraformaldehyde-fixed, autologous lymphoblasts which had been infected with recombinant vaccinia viruses expressing FIV GAG or ENV proteins. Unstimulated lymphocytes were also used as effectors in some assays. 51Cr-labelled autologous skin fibroblasts infected with recombinant vaccinia viruses were used as targets. FIV GAG-specific cytotoxic precursors were detected in restimulated circulating lymphocytes during acute infection in both cats. The onset of this activity was as early as 2 weeks postinfection (p.i.) in one cat. From 62 weeks p.i. neither FIV GAG- nor ENV-specific precursors could be detected in the peripheral blood. However, at 127 weeks p.i., GAG- and ENV-specific cytotoxic precursors were detected in lymphocytes isolated from lymph nodes. The FIV-specific cytotoxic cells were predominantly major histocompatibility complex class I restricted. No cytotoxic activity was detected from unstimulated lymphocytes. These studies demonstrate the use of an assay system for dissecting the FIV-specific cytotoxic cell response and show that precursor cells appear in the circulation very early after infection and prior to a detectable antibody response. Our results also suggest that the persistent high-level circulating antiviral cytotoxic T-lymphocyte responses seen in human immunodeficiency virus-infected humans may not be a feature of FIV infections in cats.
监测了两只实验感染猫免疫缺陷病毒(FIV)的猫中病毒特异性细胞毒性T淋巴细胞反应的演变。效应细胞在感染的急性期和慢性期(分别为感染后0至21周和62至127周)来源于外周血淋巴细胞,并在感染后127周来源于脾脏和淋巴结。淋巴细胞在体外被表达FIV GAG或ENV蛋白的重组痘苗病毒感染的多聚甲醛固定的自体淋巴母细胞重新刺激。在一些试验中,未刺激的淋巴细胞也用作效应细胞。用重组痘苗病毒感染的51Cr标记的自体皮肤成纤维细胞用作靶细胞。在两只猫的急性感染期间,在重新刺激的循环淋巴细胞中检测到FIV GAG特异性细胞毒性前体细胞。在一只猫中,这种活性的出现最早在感染后2周。从感染后62周起,在外周血中既未检测到FIV GAG特异性也未检测到ENV特异性前体细胞。然而,在感染后127周,在从淋巴结分离的淋巴细胞中检测到GAG和ENV特异性细胞毒性前体细胞。FIV特异性细胞毒性细胞主要受主要组织相容性复合体I类限制。未刺激的淋巴细胞未检测到细胞毒性活性。这些研究证明了一种用于剖析FIV特异性细胞毒性细胞反应的检测系统的用途,并表明前体细胞在感染后很早就在循环中出现,且早于可检测到的抗体反应。我们的结果还表明,在人类免疫缺陷病毒感染的人类中所见的持续高水平循环抗病毒细胞毒性T淋巴细胞反应可能不是猫FIV感染的特征。